Molecular profile of bladder cancer progression to clinically aggressive subtypes
CC Guo, S Lee, JG Lee, H Chen, M Zaleski… - Nature Reviews …, 2024 - nature.com
Bladder cancer is a histologically and clinically heterogenous disease. Most bladder
cancers are urothelial carcinomas, which frequently develop distinct histological subtypes …
cancers are urothelial carcinomas, which frequently develop distinct histological subtypes …
The urothelial gene regulatory network: understanding biology to improve bladder cancer management
The urothelium is a stratified epithelium composed of basal cells, one or more layers of
intermediate cells, and an upper layer of differentiated umbrella cells. Most bladder cancers …
intermediate cells, and an upper layer of differentiated umbrella cells. Most bladder cancers …
FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
The combination of targeted therapy with immune checkpoint inhibition (ICI) is an area of
intense interest. We studied the interaction of fibroblast growth factor receptor (FGFR) …
intense interest. We studied the interaction of fibroblast growth factor receptor (FGFR) …
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation
J Ma, L Li, B Ma, T Liu, Z Wang, Q Ye, Y Peng… - Nature …, 2024 - nature.com
Abstract CDK4/6 inhibitors (CDK4/6i) show anticancer activity in certain human
malignancies, such as breast cancer. However, their application to other tumor types and …
malignancies, such as breast cancer. However, their application to other tumor types and …
p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response
F Serra, A Nieto-Aliseda, L Fanlo-Escudero… - Nature …, 2024 - nature.com
Activation of the p53 tumor suppressor triggers a transcriptional program to control cellular
response to stress. However, the molecular mechanisms by which p53 controls gene …
response to stress. However, the molecular mechanisms by which p53 controls gene …
Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes
A Khoo, M Govindarajan, Z Qiu, LY Liu… - Nature …, 2024 - nature.com
Urine is a complex biofluid that reflects both overall physiologic state and the state of the
genitourinary tissues through which it passes. It contains both secreted proteins and proteins …
genitourinary tissues through which it passes. It contains both secreted proteins and proteins …
The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer
M Di Nardo, S Astigiano, S Baldari, MM Pallotta… - Journal of Experimental …, 2024 - Springer
Background SMC1A is a subunit of the cohesin complex that participates in many DNA-and
chromosome-related biological processes. Previous studies have established that SMC1A is …
chromosome-related biological processes. Previous studies have established that SMC1A is …
Non-small cell lung carcinoma with clear cell features and FGFR3:: TACC3 gene rearrangement: clinicopathologic and next generation sequencing study of 7 cases
D Suster, AC Mackinnon, N Ronen… - The American Journal …, 2024 - journals.lww.com
Seven cases of primary lung tumors characterized histologically by clear cell morphology
and a distinctive FGFR3:: TACC3 gene rearrangement are described. The tumors arose in 4 …
and a distinctive FGFR3:: TACC3 gene rearrangement are described. The tumors arose in 4 …
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation
BJ Viergever, DAE Raats, V Geurts… - British journal of …, 2024 - nature.com
Background Bladder cancer is one of the most common cancer types worldwide. Generally,
research relies on invasive sampling strategies. Methods Here, we generate bladder cancer …
research relies on invasive sampling strategies. Methods Here, we generate bladder cancer …
The sex gap in bladder cancer survival—a missing link in bladder cancer care?
P Toren, A Wilkins, K Patel, A Burley, T Gris… - Nature Reviews …, 2024 - nature.com
The differences in bladder cancer outcomes between the sexes has again been highlighted.
Uncommon among cancers, bladder cancer outcomes are notably worse for women than for …
Uncommon among cancers, bladder cancer outcomes are notably worse for women than for …